NASDAQ
OPNT

Opiant Pharmaceuticals Inc

METAL MINING
ENERGY & TRANSPORTATION

Prices are adjusted according to historical splits.

Opiant Pharmaceuticals Inc Stock Price

Vitals

Today's Low:
$9.6200
Today's High:
$10.3100
Open Price:
$9.8300
52W Low:
$7.34
52W High:
$37.71
Prev. Close:
$9.9000
Volume:
16352

Company Statistics

Market Cap.:
$0.052 billion
Book Value:
5.78
Revenue TTM:
$0.039 billion
Operating Margin TTM:
-46.5%
Gross Profit TTM:
$0.022 billion
Gross Profit TTM:
$0.022 billion
Profit Margin:
-51.3%
Return on Assets TTM:
-20.3%
Return on Equity TTM:
-59.9%

Company Profile

Opiant Pharmaceuticals Inc had its IPO on 2016-01-04 under the ticker symbol OPNT.

The company operates in the ENERGY & TRANSPORTATION sector and METAL MINING industry. Opiant Pharmaceuticals Inc has a staff strength of 0 employees.

Stock update

Shares of Opiant Pharmaceuticals Inc opened at $9.83 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $9.62 - $10.31, and closed at $10.16.

This is a +2.63% increase from the previous day's closing price.

A total volume of 16,352 shares were traded at the close of the day’s session.

In the last one week, shares of Opiant Pharmaceuticals Inc have increased by +1.6%.

Opiant Pharmaceuticals Inc's Key Ratios

Opiant Pharmaceuticals Inc has a market cap of $0.052 billion, indicating a price to book ratio of 1.695 and a price to sales ratio of 1.363.

In the last 12-months Opiant Pharmaceuticals Inc’s revenue was $0.039 billion with a gross profit of $0.022 billion and an EBITDA of $-0.018 billion. The EBITDA ratio measures Opiant Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Opiant Pharmaceuticals Inc’s operating margin was -46.5% while its return on assets stood at -20.3% with a return of equity of -59.9%.

In Q2.3333333333333, Opiant Pharmaceuticals Inc’s quarterly earnings growth was a positive 273.3% while revenue growth was a negative 65.4%.

Opiant Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE
26.74
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-1.365 per share while it has a forward price to earnings multiple of 26.74 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Opiant Pharmaceuticals Inc’s profitability.

Opiant Pharmaceuticals Inc stock is trading at a EV to sales ratio of 0.773 and a EV to EBITDA ratio of -1.42. Its price to sales ratio in the trailing 12-months stood at 1.363.

Opiant Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Opiant Pharmaceuticals Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Opiant Pharmaceuticals Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Opiant Pharmaceuticals Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Opiant Pharmaceuticals Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Opiant Pharmaceuticals Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$10.16
52-Week High
$37.71
52-Week Low
$7.34
Analyst Target Price
$40.33

Opiant Pharmaceuticals Inc stock is currently trading at $10.16 per share. It touched a 52-week high of $37.71 and a 52-week low of $37.71. Analysts tracking the stock have a 12-month average target price of $40.33.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Opiant Pharmaceuticals Inc

The stock symbol (also called stock or share ticker) of Opiant Pharmaceuticals Inc is OPNT

The IPO of Opiant Pharmaceuticals Inc took place on 2016-01-04

Similar Industry Stocks (METAL MINING)

Last Price
Chg
Chg%
$3.95
-0.32
-7.49%
$12.24
-1.11
-8.31%
New Gold Inc (NGD)
$0.87
-0.05
-4.95%
$0.18
-0.02
-10.32%
$15.05
0
0%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops drugs for addiction and drug overdose. The company is headquartered in Santa Monica, California.

Address

445 PARK AVENUE, 9TH FLOOR, NEW YORK, NY, US